|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| C07B 59/00 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Patento numeris | 3450434 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18188152.5 |
| Europos patento paraiškos padavimo data | 2013-06-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-02-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261660428 P | 2012-06-15 | US | |
| 201261678795 P | 2012-08-02 | US |
| (72) |
SILVERMAN, I. Robert, US
LIU, Julie F., US
MORGAN, Adam J., US
PANDYA, Bhaumik, US
HARBESON, Scott L., US
|
| (73) |
CoNCERT Pharmaceuticals, Inc.,
65 Hayden Avenue, Suite 3000N, Lexington, MA 02421,
US
|
| (54) | DEUTERATED DERIVATIVES OF RUXOLITINIB |
| DEUTERATED DERIVATIVES OF RUXOLITINIB |